Paediatric treatment trials for COVID-19 are an ethical imperative.

Gwee, Amanda; Boast, Alison; Osowicki, Joshua; Steer, Andrew C; Coghlan, Simon

Gwee, Amanda; Boast, Alison; Osowicki, Joshua; Steer, Andrew C; Coghlan, Simon.

Gwee A; Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne Department of General Medicine, Parkville, Victoria, Australia amanda.gwee@rch.org.au.
Boast A; Infection and Immunity theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Osowicki J; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Steer AC; Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Coghlan S; Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne Department of General Medicine, Parkville, Victoria, Australia.

Arch Dis Child ; 106(2): e4, 2021 02.

Article in English | MEDLINE | ID: covidwho-592161

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Child Welfare/ethics; Clinical Trials as Topic/ethics; Therapeutic Human Experimentation/ethics; Child; Humans

Keywords

ethics; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Child Welfare / Clinical Trials as Topic / Therapeutic Human Experimentation / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Child / Humans Language: English Journal: Arch Dis Child Year: 2021 Document Type: Article Affiliation country: Archdischild-2020-319701

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google